John Hoekman is Chief Scientific Officer of Impel Pharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Feb 23 | IMPLQ Impel Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 2.29 | 42,500 | 97.33 k | 42,500 |